Dolby Laboratories (DLB) Total Current Liabilities (2009 - 2026)
Dolby Laboratories' (DLB) quarterly Total Current Liabilities came in at $416.3 million in Q2 2026, up 7.08% YoY from $388.8 million in Q2 2025, and down 12.28% on a QoQ basis from $474.6 million in Q1 2026.
Dolby Laboratories (DLB) Total Current Liabilities (2009 - 2026) Analysis & Trends
Dolby Laboratories (DLB) has 18 years of Total Current Liabilities data on file, last reported at $416.3 million in Q2 2026.
- Quarterly Total Current Liabilities rose 7.08% year-over-year to $416.3 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $416.3 million (up 7.08% YoY) and the FY2025 annual result came in at $437.8 million, up 4.78% from the prior year.
- Total Current Liabilities fell to $416.3 million in Q2 2026, from $474.6 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $474.6 million in Q1 2026 to a low of $277.5 million in Q3 2022.
- A 5-year average of $386.9 million and a median of $417.1 million in 2024 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2023 — Total Current Liabilities soared 52.14% — and 2024, when it dropped 16.19%.
- Tracing DLB's Total Current Liabilities over 5 years: stood at $290.4 million in 2022, then soared by 35.69% to $394.1 million in 2023, then grew by 12.12% to $441.9 million in 2024, then grew by 0.37% to $443.5 million in 2025, then dropped by 6.13% to $416.3 million in 2026.
- The last three Total Current Liabilities figures came in at $416.3 million (Q2 2026), $474.6 million (Q1 2026), and $443.5 million (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Cintas | 81.69 Bn | 81.40 Bn | 1.48 Bn | 2.69 Bn |
| 2 | Relx | 64.97 Bn | 64.80 Bn | - | 7.98 Bn |
| 3 | Copart | 32.09 Bn | 28.74 Bn | 732.88 Mn | 685.26 Mn |
| 4 | Global Payments | 24.80 Bn | 19.40 Bn | 2.03 Bn | 14.15 Bn |
| 5 | Rb Global | 16.24 Bn | 15.72 Bn | 935.50 Mn | 1.44 Bn |
| 6 | Aramark | 15.68 Bn | 15.18 Bn | 430.34 Mn | 3.00 Bn |
| 7 | UL Solutions | 15.20 Bn | 14.77 Bn | 417.00 Mn | 866.00 Mn |
| 8 | Rentokil Initial | 11.80 Bn | 9.27 Bn | - | -6.00 Mn |
| 9 | Dolby Laboratories | 6.05 Bn | 5.38 Bn | 264.68 Mn | 416.33 Mn |
| 10 | Unifirst | 5.23 Bn | 5.06 Bn | 234.73 Mn | 295.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 26, 2026 | 416.33 Mn |
| Mar 27, 2026 | 474.61 Mn |
| Dec 26, 2025 | 443.51 Mn |
| Sep 26, 2025 | 437.79 Mn |
| Jun 27, 2025 | 388.79 Mn |
| Mar 28, 2025 | 457.49 Mn |
| Dec 27, 2024 | 441.88 Mn |
| Sep 27, 2024 | 417.84 Mn |
| Jun 28, 2024 | 354.54 Mn |
| Mar 29, 2024 | 442.90 Mn |
| Dec 29, 2023 | 394.10 Mn |
| Sep 29, 2023 | 422.23 Mn |
| Jun 30, 2023 | 423.04 Mn |
| Mar 31, 2023 | 314.01 Mn |
| Dec 30, 2022 | 290.45 Mn |
| Sep 30, 2022 | 277.52 Mn |
| Jul 1, 2022 | 285.49 Mn |
| Apr 1, 2022 | 280.96 Mn |
| Dec 31, 2021 | 283.29 Mn |
| Sep 24, 2021 | 315.72 Mn |